Correlation Between Blueprint Medicines and Eton Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Eton Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Eton Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Eton Pharmaceuticals, you can compare the effects of market volatilities on Blueprint Medicines and Eton Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Eton Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Eton Pharmaceuticals.
Diversification Opportunities for Blueprint Medicines and Eton Pharmaceuticals
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Blueprint and Eton is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Eton Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eton Pharmaceuticals and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Eton Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eton Pharmaceuticals has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Eton Pharmaceuticals go up and down completely randomly.
Pair Corralation between Blueprint Medicines and Eton Pharmaceuticals
Given the investment horizon of 90 days Blueprint Medicines is expected to generate 2.88 times less return on investment than Eton Pharmaceuticals. But when comparing it to its historical volatility, Blueprint Medicines Corp is 1.52 times less risky than Eton Pharmaceuticals. It trades about 0.2 of its potential returns per unit of risk. Eton Pharmaceuticals is currently generating about 0.39 of returns per unit of risk over similar time horizon. If you would invest 842.00 in Eton Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 403.00 from holding Eton Pharmaceuticals or generate 47.86% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Blueprint Medicines Corp vs. Eton Pharmaceuticals
Performance |
| Timeline |
| Blueprint Medicines Corp |
| Eton Pharmaceuticals |
Blueprint Medicines and Eton Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Blueprint Medicines and Eton Pharmaceuticals
The main advantage of trading using opposite Blueprint Medicines and Eton Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Eton Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eton Pharmaceuticals will offset losses from the drop in Eton Pharmaceuticals' long position.| Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
| Eton Pharmaceuticals vs. Phibro Animal Health | Eton Pharmaceuticals vs. Procaps Group SA | Eton Pharmaceuticals vs. Amphastar P | Eton Pharmaceuticals vs. Alkermes Plc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |